CDKL5 and craniodiaphyseal dysplasia: To examine the translational potential of these findings, we generated a novel CDD model bearing a patient mutation, CDKL5 R59X, and found that these mice, similarly to Dlx-cKO mice, show an elevation of NMDA receptors.